RxDoctor Payments Data

Gansevoort Dunnington

Interventional Cardiology · Richmond, VANPI 1740200880

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $439,594 of the $440,269 with a category attached, or 99.8%. Pulse Biosciences, Inc. accounts for 100.0% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $440,132, more than ten times the $34 reported in 2019. Among interventional cardiology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$440,269in general payments, 2019–2025

Across 38 payments — averaging $11,586 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pulse Biosciences, Inc.$440K
  • Inari Medical, Inc.$87
  • Biotronik Inc.$22
  • Kls-martin L.p.$16
  • Irhythm Technologies, Inc.$12

What the payments were for

  • Consulting fees$439,594100%
  • Food & beverage$6740%

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$440,269 in reported general payments places this provider in the 95th percentile of 176 interventional cardiology providers in Virginia.

See all interventional cardiology providers in Virginia

Other interventional cardiology in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →